Kythera Biopharmaceuticals Inc Asset Turnover Ratio (KYTH), as of second quarter 2015, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Kythera Biopharmaceuticals Inc  (KYTH)
 

Kythera Biopharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Jun 30 2015, Kythera Biopharmaceuticals Inc has not recorded any assets.
Visit Kythera Biopharmaceuticals Inc Balance sheet

Within sector Kythera Biopharmaceuticals Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2015 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KYTH Asset Turnover Ratio (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter
Y / Y Asset Change 40.85 % 38.33 % -40.36 % 88.3 % 81.66 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0 - - - -
KYTH's Total Ranking # # # # #
Seq. Asset Change -9.22 % 108.17 % -15.04 % -12.27 % -10.85 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




KYTH Company Profile • Back to KYTH Efficiency Comparisons • Compare KYTH Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2015, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2015 Assets at quarter ending Jun 30 2015
Ampio Pharmaceuticals inc 0.00 $ 0.249  Millions$ 66.991  Millions
Adverum Biotechnologies Inc 0.00 $ 0.813  Millions$ 226.388  Millions
Aratana Therapeutics, Inc. 0.00 $ 0.677  Millions$ 202.359  Millions
Arrowhead Pharmaceuticals Inc 0.00 $ 0.382  Millions$ 168.301  Millions
Revance Therapeutics Inc 0.00 $ 0.300  Millions$ 187.082  Millions
Sophiris Bio Inc. 0.00 $ 0.036  Millions$ 23.273  Millions
Tg Therapeutics Inc 0.00 $ 0.152  Millions$ 101.291  Millions
Intra cellular Therapies Inc 0.00 $ 0.251  Millions$ 179.813  Millions
Accelerate Diagnostics Inc 0.00 $ 0.128  Millions$ 100.262  Millions
Aceragen Inc 0.00 $ 0.071  Millions$ 85.550  Millions
Palisade Bio Inc 0.00 $ 0.015  Millions$ 29.115  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.